arrow
J

Jan-Patrick Stellmann

cemerem
H指数:28
被引数:3,628

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Twelve-week intermittent hypoxia intervention in multiple sclerosis – a safety and feasibility trial

多发性硬化患者12周间歇性低氧干预——一项安全性与可行性试验

2026-04-020
OAAI
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

关于NMOSD和MOGAD免疫疗法的选择和有效性的真实世界多中心队列研究

2024-12-270
PRE
Cognition in patients with myelin oligodendrocyte glycoprotein antibody-associated disease: a prospective, longitudinal, multicentre study of 113 patients (CogniMOG-Study)
2024-07-301
PRE
Evolution of retinal degeneration and prediction of disease activity in relapsing and progressive multiple sclerosis
2024-06-191
OAAI
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD
2024-01-1322
OAAI
Physical fitness moderates the association between brain network impairment and both motor function and cognition in progressive multiple sclerosis

身体机能调节了脑网络功能损伤与运动功能和认知功能之间的关联,在多发性硬化进展过程中。

2023-06-210
PRE
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases COPANMO(G)-Study
2023-03-017
OAAI
Cognition in patients with neuromyelitis optica spectrum disorders: A prospective multicentre study of 217 patients (CogniNMO-Study)
2023-02-1410
OAAI
Costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Disease CHANCENMO Study
2022-03-1517
OAAI
Interleukin-6 Receptor Blockade in Treatment-Refractory MOG-IgG-Associated Disease and Neuromyelitis Optica Spectrum Disorders
2022-01-0182
OAAI
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients
2021-05-0153
OAAI